GLMD
Price
$0.84
Change
+$0.03 (+3.70%)
Updated
Nov 21 closing price
Capitalization
4.59M
One day until earnings call
Intraday BUY SELL Signals
TPST
Price
$3.50
Change
-$0.18 (-4.89%)
Updated
Nov 21 closing price
Capitalization
15.54M
Intraday BUY SELL Signals
Interact to see
Advertisement

GLMD vs TPST

Header iconGLMD vs TPST Comparison
Open Charts GLMD vs TPSTBanner chart's image
Galmed Pharmaceuticals
Price$0.84
Change+$0.03 (+3.70%)
Volume$391.97K
Capitalization4.59M
Tempest Therapeutics
Price$3.50
Change-$0.18 (-4.89%)
Volume$287.69K
Capitalization15.54M
GLMD vs TPST Comparison Chart in %
GLMD
Daily Signal:
Gain/Loss:
TPST
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GLMD vs. TPST commentary
Nov 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLMD is a Hold and TPST is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 23, 2025
Stock price -- (GLMD: $0.84 vs. TPST: $3.50)
Brand notoriety: GLMD and TPST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLMD: 15% vs. TPST: 378%
Market capitalization -- GLMD: $4.59M vs. TPST: $15.54M
GLMD [@Biotechnology] is valued at $4.59M. TPST’s [@Biotechnology] market capitalization is $15.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $108.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLMD’s FA Score shows that 1 FA rating(s) are green whileTPST’s FA Score has 0 green FA rating(s).

  • GLMD’s FA Score: 1 green, 4 red.
  • TPST’s FA Score: 0 green, 5 red.
According to our system of comparison, both GLMD and TPST are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLMD’s TA Score shows that 4 TA indicator(s) are bullish while TPST’s TA Score has 4 bullish TA indicator(s).

  • GLMD’s TA Score: 4 bullish, 5 bearish.
  • TPST’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, GLMD is a better buy in the short-term than TPST.

Price Growth

GLMD (@Biotechnology) experienced а -19.51% price change this week, while TPST (@Biotechnology) price change was -61.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.01%. For the same industry, the average monthly price growth was -3.31%, and the average quarterly price growth was +62.87%.

Reported Earning Dates

GLMD is expected to report earnings on Nov 24, 2025.

Industries' Descriptions

@Biotechnology (-1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TPST($15.5M) has a higher market cap than GLMD($4.59M). TPST YTD gains are higher at: -67.737 vs. GLMD (-73.759). GLMD has higher annual earnings (EBITDA): -7.03M vs. TPST (-42.04M). GLMD has more cash in the bank: 20.5M vs. TPST (14.3M). GLMD has less debt than TPST: GLMD (41K) vs TPST (8.66M). GLMD (0) and TPST (0) have equivalent revenues.
GLMDTPSTGLMD / TPST
Capitalization4.59M15.5M30%
EBITDA-7.03M-42.04M17%
Gain YTD-73.759-67.737109%
P/E Ratio0.02N/A-
Revenue00-
Total Cash20.5M14.3M143%
Total Debt41K8.66M0%
FUNDAMENTALS RATINGS
GLMD vs TPST: Fundamental Ratings
GLMD
TPST
OUTLOOK RATING
1..100
9962
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
39
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
95100
PRICE GROWTH RATING
1..100
9497
P/E GROWTH RATING
1..100
9486
SEASONALITY SCORE
1..100
3550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GLMD's Valuation (30) in the Pharmaceuticals Other industry is in the same range as TPST (39) in the Pharmaceuticals Major industry. This means that GLMD’s stock grew similarly to TPST’s over the last 12 months.

GLMD's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as TPST (100) in the Pharmaceuticals Major industry. This means that GLMD’s stock grew similarly to TPST’s over the last 12 months.

GLMD's SMR Rating (95) in the Pharmaceuticals Other industry is in the same range as TPST (100) in the Pharmaceuticals Major industry. This means that GLMD’s stock grew similarly to TPST’s over the last 12 months.

GLMD's Price Growth Rating (94) in the Pharmaceuticals Other industry is in the same range as TPST (97) in the Pharmaceuticals Major industry. This means that GLMD’s stock grew similarly to TPST’s over the last 12 months.

TPST's P/E Growth Rating (86) in the Pharmaceuticals Major industry is in the same range as GLMD (94) in the Pharmaceuticals Other industry. This means that TPST’s stock grew similarly to GLMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GLMDTPST
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 5 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
GLMD
Daily Signal:
Gain/Loss:
TPST
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COMM17.200.63
+3.80%
CommScope Holding Company
RDDT183.481.60
+0.88%
Reddit
CRBU1.75N/A
N/A
Caribou Biosciences
AIV5.62-0.02
-0.35%
Apartment Investment and Management Company
AKTX0.45-0.01
-2.66%
Akari Therapeutics plc

GLMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLMD has been closely correlated with XBIO. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if GLMD jumps, then XBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLMD
1D Price
Change %
GLMD100%
+2.72%
XBIO - GLMD
88%
Closely correlated
+4.76%
GBIO - GLMD
34%
Loosely correlated
+0.08%
TPST - GLMD
34%
Loosely correlated
-4.89%
ARQT - GLMD
32%
Poorly correlated
+7.90%
ARWR - GLMD
32%
Poorly correlated
+6.20%
More

TPST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TPST has been loosely correlated with AGIO. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if TPST jumps, then AGIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TPST
1D Price
Change %
TPST100%
-4.89%
AGIO - TPST
57%
Loosely correlated
+2.73%
PHIO - TPST
49%
Loosely correlated
-5.88%
TYRA - TPST
41%
Loosely correlated
+0.57%
NRIX - TPST
40%
Loosely correlated
+9.33%
BEAM - TPST
40%
Loosely correlated
+7.82%
More